Advertisement

Advertisement

JP:4583 Stock Latest News

Chiome Bioscience Outlines Q2 FY2026 Results and R&D Focus

Company AnnouncementsChiome Bioscience Outlines Q2 FY2026 Results and R&D Focus

Chiome Bioscience Narrows Losses as Sales Rise and Balance Sheet Strengthens

PremiumCompany Announcements

Chiome Bioscience Narrows Losses as Sales Rise and Balance Sheet Strengthens

24d ago

Chiome Bioscience Outlines Q1 FY2026 Results and Pipeline Focus

PremiumCompany Announcements

Chiome Bioscience Outlines Q1 FY2026 Results and Pipeline Focus

4M ago

Chiome Bioscience Narrows Quarterly Loss as Equity Ratio Improves, Keeps Cautious Outlook

PremiumCompany Announcements

Chiome Bioscience Narrows Quarterly Loss as Equity Ratio Improves, Keeps Cautious Outlook

4M ago

Chiome Bioscience Corrects FY2025 Results as Losses and Cash Burn Persist

PremiumCompany Announcements

Chiome Bioscience Corrects FY2025 Results as Losses and Cash Burn Persist

5M ago

Chiome Bioscience Outlines FY2025 Results and mAb Development Focus

PremiumCompany AnnouncementsChiome Bioscience Outlines FY2025 Results and mAb Development Focus

7M ago

Chiome Bioscience Widens Cash Burn as Sales Drop and Outlook Stays Limited

Company Announcements

Chiome Bioscience Widens Cash Burn as Sales Drop and Outlook Stays Limited

7M ago

Chiome Bioscience Reports Continued Losses Amidst Declining Sales

Company Announcements

Chiome Bioscience Reports Continued Losses Amidst Declining Sales

10M ago

Chiome Bioscience’s CBA-1205: A Promising Phase I Study Update

PremiumCompany Announcements

Chiome Bioscience’s CBA-1205: A Promising Phase I Study Update

10M ago

Chiome Bioscience’s Innovative Phase I Study on CBA-1535: A Potential Game-Changer in Cancer Treatment

PremiumCompany Announcements

Chiome Bioscience’s Innovative Phase I Study on CBA-1535: A Potential Game-Changer in Cancer Treatment

10M ago

Chiome Bioscience Reports First Half 2025 Financial Results

PremiumCompany Announcements

Chiome Bioscience Reports First Half 2025 Financial Results

1y ago

Chiome Bioscience Reports Q1 2025 Financial Results Amid Continued Losses

PremiumCompany Announcements

Chiome Bioscience Reports Q1 2025 Financial Results Amid Continued Losses

1y ago

Chiome Bioscience Updates Financial Results for FY 2024

PremiumCompany AnnouncementsChiome Bioscience Updates Financial Results for FY 2024

1y ago

Chiome Bioscience and OmniAb Collaborate on Antibody Research

Company Announcements

Chiome Bioscience and OmniAb Collaborate on Antibody Research

2y ago

Chiome Bioscience Reports Modest Sales Growth Amid Continued Financial Challenges

Company Announcements

Chiome Bioscience Reports Modest Sales Growth Amid Continued Financial Challenges

2y ago

Chiome Bioscience’s Tribody™ Technology Shows Promising Results in Cancer Immunotherapy

PremiumCompany Announcements

Chiome Bioscience’s Tribody™ Technology Shows Promising Results in Cancer Immunotherapy

2y ago

Chiome Bioscience’s Promising Results in CBA-1205 Phase I Study

PremiumCompany Announcements

Chiome Bioscience’s Promising Results in CBA-1205 Phase I Study

2y ago

Chiome Bioscience Unveils Promising Cancer Therapy Data

PremiumCompany Announcements

Chiome Bioscience Unveils Promising Cancer Therapy Data

2y ago

Chiome Bioscience Secures Licensing Deal with Asahi Kasei

PremiumCompany Announcements

Chiome Bioscience Secures Licensing Deal with Asahi Kasei

2y ago

Chiome Bioscience Secures Key Licensing Deal

PremiumCompany AnnouncementsChiome Bioscience Secures Key Licensing Deal

2y ago

Chiome Bioscience Revises Forecast Amid Financial Challenges

Company Announcements

Chiome Bioscience Revises Forecast Amid Financial Challenges

2y ago

Chiome Bioscience Reports Decreased Half-Year Results

Company Announcements

Chiome Bioscience Reports Decreased Half-Year Results

2y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >